We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
CYLD
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • CYLD
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

CYLD
Synonyms CYLD1, KIAA0849, USPL2
Gene descriptioni

Full gene name according to HGNC.

CYLD lysine 63 deubiquitinase
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Cancer-related genes
Disease related genes
Enzymes
Human disease related genes
Metabolic proteins
Potential drug targets
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 16
Cytoband q12.1
Chromosome location (bp) 50742050 - 50801935
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

11
Ensembl ENSG00000083799 (version 109)
Entrez gene 1540
HGNC HGNC:2584
UniProt Q9NQC7 (UniProt - Evidence at protein level)
neXtProt NX_Q9NQC7
GeneCards CYLD
Antibodypedia CYLD antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis 1, 2, 3, 4, 5, 6, 7, 8. Negatively regulates NF-kappa-B activation by deubiquitinating upstream signaling factors 9, 10, 11. Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation 12. Negative regulator of Wnt signaling 13. Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules 14. Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis 15, 16. Required for normal cell cycle progress and normal cytokinesis 17, 18. Inhibits nuclear translocation of NF-kappa-B 19. Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation 20. Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells (By similarity). Negatively regulates TNFRSF11A signaling and osteoclastogenesis (By similarity). Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation (By similarity). Ability to remove linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via interaction with SPATA2 and restricts linear polyubiquitin formation on target proteins 21, 22, 23, 24. Regulates innate immunity by restricting linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation 25. Involved in TNF-alpha-induced necroptosis by removing linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby regulating the kinase activity of RIPK1 (By similarity). Negatively regulates intestinal inflammation by removing 'Lys-63' linked polyubiquitin chain of NLRP6, thereby reducing the interaction between NLRP6 and PYCARD/ASC and formation of the NLRP6 inflammasome (By similarity). Removes 'Lys-63' linked polyubiquitin chain of MAP3K7, which inhibits phosphorylation and blocks downstream activation of the JNK-p38 kinase cascades 26. Removes also 'Lys-63'-linked polyubiquitin chains of MAP3K1 and MA3P3K3, which inhibit their interaction with MAP2K1 and MAP2K2 27.... show less
Molecular function (UniProt)i

Keywords assigned by UniProt to proteins due to their particular molecular function.

Hydrolase, Protease, Thiol protease
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway
Ligand (UniProt)i

Keywords assigned by UniProt to proteins because they bind, are associated with, or whose activity is dependent of some molecule.

Metal-binding, Zinc
Gene summary (Entrez)i

Useful information about the gene from Entrez

This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
CYLD-201
ENSP00000308928
ENST00000311559
Q9NQC7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   Peptidases
   Cysteine-type peptidases
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005874 [microtubule]
GO:0005881 [cytoplasmic microtubule]
GO:0005886 [plasma membrane]
GO:0006508 [proteolysis]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0007049 [cell cycle]
GO:0007346 [regulation of mitotic cell cycle]
GO:0008233 [peptidase activity]
GO:0008234 [cysteine-type peptidase activity]
GO:0008270 [zinc ion binding]
GO:0010803 [regulation of tumor necrosis factor-mediated signaling pathway]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0016787 [hydrolase activity]
GO:0019901 [protein kinase binding]
GO:0030496 [midbody]
GO:0031234 [extrinsic component of cytoplasmic side of plasma membrane]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0036064 [ciliary basal body]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0046329 [negative regulation of JNK cascade]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050727 [regulation of inflammatory response]
GO:0050728 [negative regulation of inflammatory response]
GO:0060544 [regulation of necroptotic process]
GO:0061578 [Lys63-specific deubiquitinase activity]
GO:0070064 [proline-rich region binding]
GO:0070266 [necroptotic process]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070507 [regulation of microtubule cytoskeleton organization]
GO:0070536 [protein K63-linked deubiquitination]
GO:0090090 [negative regulation of canonical Wnt signaling pathway]
GO:0097542 [ciliary tip]
GO:1901223 [negative regulation of NIK/NF-kappaB signaling]
GO:1902017 [regulation of cilium assembly]
GO:1903753 [negative regulation of p38MAPK cascade]
GO:1990108 [protein linear deubiquitination]
GO:2000493 [negative regulation of interleukin-18-mediated signaling pathway]
GO:2001238 [positive regulation of extrinsic apoptotic signaling pathway]
GO:2001242 [regulation of intrinsic apoptotic signaling pathway]
Show all
956 aa
107.3 kDa
No 0
CYLD-202
ENSP00000381574
ENST00000398568
Q9NQC7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
A0A024R6T1
[Target identity:100%; Query identity:100%] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   Peptidases
   Cysteine-type peptidases
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005874 [microtubule]
GO:0005881 [cytoplasmic microtubule]
GO:0005886 [plasma membrane]
GO:0006508 [proteolysis]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0007049 [cell cycle]
GO:0007346 [regulation of mitotic cell cycle]
GO:0008233 [peptidase activity]
GO:0008234 [cysteine-type peptidase activity]
GO:0008270 [zinc ion binding]
GO:0010803 [regulation of tumor necrosis factor-mediated signaling pathway]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0016787 [hydrolase activity]
GO:0019901 [protein kinase binding]
GO:0030496 [midbody]
GO:0031234 [extrinsic component of cytoplasmic side of plasma membrane]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0036064 [ciliary basal body]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0046329 [negative regulation of JNK cascade]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050727 [regulation of inflammatory response]
GO:0050728 [negative regulation of inflammatory response]
GO:0060544 [regulation of necroptotic process]
GO:0061578 [Lys63-specific deubiquitinase activity]
GO:0070064 [proline-rich region binding]
GO:0070266 [necroptotic process]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070507 [regulation of microtubule cytoskeleton organization]
GO:0070536 [protein K63-linked deubiquitination]
GO:0090090 [negative regulation of canonical Wnt signaling pathway]
GO:0097542 [ciliary tip]
GO:1901223 [negative regulation of NIK/NF-kappaB signaling]
GO:1902017 [regulation of cilium assembly]
GO:1903753 [negative regulation of p38MAPK cascade]
GO:1990108 [protein linear deubiquitination]
GO:2000493 [negative regulation of interleukin-18-mediated signaling pathway]
GO:2001238 [positive regulation of extrinsic apoptotic signaling pathway]
GO:2001242 [regulation of intrinsic apoptotic signaling pathway]
Show all
953 aa
107 kDa
No 0
CYLD-203
ENSP00000392025
ENST00000427738
Q9NQC7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   Peptidases
   Cysteine-type peptidases
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005874 [microtubule]
GO:0005881 [cytoplasmic microtubule]
GO:0005886 [plasma membrane]
GO:0006508 [proteolysis]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0007049 [cell cycle]
GO:0007346 [regulation of mitotic cell cycle]
GO:0008233 [peptidase activity]
GO:0008234 [cysteine-type peptidase activity]
GO:0008270 [zinc ion binding]
GO:0010803 [regulation of tumor necrosis factor-mediated signaling pathway]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0016787 [hydrolase activity]
GO:0019901 [protein kinase binding]
GO:0030496 [midbody]
GO:0031234 [extrinsic component of cytoplasmic side of plasma membrane]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0036064 [ciliary basal body]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0046329 [negative regulation of JNK cascade]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050727 [regulation of inflammatory response]
GO:0050728 [negative regulation of inflammatory response]
GO:0060544 [regulation of necroptotic process]
GO:0061578 [Lys63-specific deubiquitinase activity]
GO:0070064 [proline-rich region binding]
GO:0070266 [necroptotic process]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070507 [regulation of microtubule cytoskeleton organization]
GO:0070536 [protein K63-linked deubiquitination]
GO:0090090 [negative regulation of canonical Wnt signaling pathway]
GO:0097542 [ciliary tip]
GO:1901223 [negative regulation of NIK/NF-kappaB signaling]
GO:1902017 [regulation of cilium assembly]
GO:1903753 [negative regulation of p38MAPK cascade]
GO:1990108 [protein linear deubiquitination]
GO:2000493 [negative regulation of interleukin-18-mediated signaling pathway]
GO:2001238 [positive regulation of extrinsic apoptotic signaling pathway]
GO:2001242 [regulation of intrinsic apoptotic signaling pathway]
Show all
956 aa
107.3 kDa
No 0
CYLD-204
ENSP00000463197
ENST00000562884
J3QKR2
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
104 aa
11.9 kDa
No 0
CYLD-207
ENSP00000454515
ENST00000564326
Q9NQC7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
A0A024R6T1
[Target identity:100%; Query identity:100%] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   Peptidases
   Cysteine-type peptidases
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005874 [microtubule]
GO:0005881 [cytoplasmic microtubule]
GO:0005886 [plasma membrane]
GO:0006508 [proteolysis]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0007049 [cell cycle]
GO:0007346 [regulation of mitotic cell cycle]
GO:0008233 [peptidase activity]
GO:0008234 [cysteine-type peptidase activity]
GO:0008270 [zinc ion binding]
GO:0010803 [regulation of tumor necrosis factor-mediated signaling pathway]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0016787 [hydrolase activity]
GO:0019901 [protein kinase binding]
GO:0030496 [midbody]
GO:0031234 [extrinsic component of cytoplasmic side of plasma membrane]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0036064 [ciliary basal body]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0046329 [negative regulation of JNK cascade]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050727 [regulation of inflammatory response]
GO:0050728 [negative regulation of inflammatory response]
GO:0060544 [regulation of necroptotic process]
GO:0061578 [Lys63-specific deubiquitinase activity]
GO:0070064 [proline-rich region binding]
GO:0070266 [necroptotic process]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070507 [regulation of microtubule cytoskeleton organization]
GO:0070536 [protein K63-linked deubiquitination]
GO:0090090 [negative regulation of canonical Wnt signaling pathway]
GO:0097542 [ciliary tip]
GO:1901223 [negative regulation of NIK/NF-kappaB signaling]
GO:1902017 [regulation of cilium assembly]
GO:1903753 [negative regulation of p38MAPK cascade]
GO:1990108 [protein linear deubiquitination]
GO:2000493 [negative regulation of interleukin-18-mediated signaling pathway]
GO:2001238 [positive regulation of extrinsic apoptotic signaling pathway]
GO:2001242 [regulation of intrinsic apoptotic signaling pathway]
Show all
953 aa
107 kDa
No 0
CYLD-208
ENSP00000455535
ENST00000564634
H3BPZ5
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
33 aa
4 kDa
No 0
CYLD-209
ENSP00000458507
ENST00000566024
I3L117
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
66 aa
7.2 kDa
No 0
CYLD-210
ENSP00000462134
ENST00000566206
J3KRR7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005886 [plasma membrane]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0048471 [perinuclear region of cytoplasm]
Show all
910 aa
101.9 kDa
No 0
CYLD-211
ENSP00000456912
ENST00000566679
H3BSW9
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
304 aa
33.9 kDa
No 0
CYLD-212
ENSP00000456488
ENST00000568704
H3BS09
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005886 [plasma membrane]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0048471 [perinuclear region of cytoplasm]
Show all
771 aa
87.4 kDa
No 0
CYLD-214
ENSP00000457576
ENST00000569418
Q9NQC7
[Direct mapping] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
A0A024R6T1
[Target identity:100%; Query identity:100%] Ubiquitin carboxyl-terminal hydrolase CYLD
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   Peptidases
   Cysteine-type peptidases
Metabolic proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Splicing Mutations
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Germline Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Nervous system diseases
   Neurodegenerative diseases
   Skin diseases
   Skin and soft tissue diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002376 [immune system process]
GO:0004843 [cysteine-type deubiquitinase activity]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005813 [centrosome]
GO:0005815 [microtubule organizing center]
GO:0005819 [spindle]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0005874 [microtubule]
GO:0005881 [cytoplasmic microtubule]
GO:0005886 [plasma membrane]
GO:0006508 [proteolysis]
GO:0006511 [ubiquitin-dependent protein catabolic process]
GO:0007049 [cell cycle]
GO:0007346 [regulation of mitotic cell cycle]
GO:0008233 [peptidase activity]
GO:0008234 [cysteine-type peptidase activity]
GO:0008270 [zinc ion binding]
GO:0010803 [regulation of tumor necrosis factor-mediated signaling pathway]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016579 [protein deubiquitination]
GO:0016787 [hydrolase activity]
GO:0019901 [protein kinase binding]
GO:0030496 [midbody]
GO:0031234 [extrinsic component of cytoplasmic side of plasma membrane]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0036064 [ciliary basal body]
GO:0042995 [cell projection]
GO:0045087 [innate immune response]
GO:0046329 [negative regulation of JNK cascade]
GO:0046872 [metal ion binding]
GO:0048471 [perinuclear region of cytoplasm]
GO:0050727 [regulation of inflammatory response]
GO:0050728 [negative regulation of inflammatory response]
GO:0060544 [regulation of necroptotic process]
GO:0061578 [Lys63-specific deubiquitinase activity]
GO:0070064 [proline-rich region binding]
GO:0070266 [necroptotic process]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070507 [regulation of microtubule cytoskeleton organization]
GO:0070536 [protein K63-linked deubiquitination]
GO:0090090 [negative regulation of canonical Wnt signaling pathway]
GO:0097542 [ciliary tip]
GO:1901223 [negative regulation of NIK/NF-kappaB signaling]
GO:1902017 [regulation of cilium assembly]
GO:1903753 [negative regulation of p38MAPK cascade]
GO:1990108 [protein linear deubiquitination]
GO:2000493 [negative regulation of interleukin-18-mediated signaling pathway]
GO:2001238 [positive regulation of extrinsic apoptotic signaling pathway]
GO:2001242 [regulation of intrinsic apoptotic signaling pathway]
Show all
953 aa
107 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org